FOLLOWUS
Traditional Chinese medicine for modern treatment of Parkinson’s disease
Traditional Chinese medicine for modern treatment of Parkinson’s disease
- 中国结合医学杂志（英文版） 2017年23卷第8期 页码：635-640
- Affiliations：
Department of Neurology, Shanghai Tong-Ren Hospital, Shanghai Jiao Tong University School of Medicine,Shanghai,China
- Author bio：
- Funds：Supported by National Natural Science Foundation of China (No. 81071065 and No. 81671103)
DOI：10.1007/s11655-016-2537-7
中图分类号：纸质出版日期：2017，
网络出版日期：2017-1-20，
Scan for full text
Han, L., Xie, Yh., Wu, R. et al. Traditional Chinese medicine for modern treatment of Parkinson’s disease., Chin. J. Integr. Med. 23, 635–640 (2017). https://doi.org/10.1007/s11655-016-2537-7
Lu Han, Yuan-hong Xie, Rong Wu, et al. Traditional Chinese medicine for modern treatment of Parkinson’s disease[J]. Chinese Journal of Integrative Medicine, 2017,23(8):635-640.
Han, L., Xie, Yh., Wu, R. et al. Traditional Chinese medicine for modern treatment of Parkinson’s disease., Chin. J. Integr. Med. 23, 635–640 (2017). https://doi.org/10.1007/s11655-016-2537-7 DOI：
Lu Han, Yuan-hong Xie, Rong Wu, et al. Traditional Chinese medicine for modern treatment of Parkinson’s disease[J]. Chinese Journal of Integrative Medicine, 2017,23(8):635-640. DOI： 10.1007/s11655-016-2537-7.
摘要
Parkinson’s disease (PD) is a chronic and progressive degenerative disorder of brain commonly seen among the elderly. As conventionally medical therapy is of limited relief and potential side effects
complementary and alternative medicine (CAM) has attracted growing public and professional attention. Therapies such as acupuncture
musical/rhythmic therapy and deep brain stimulation have been gradually proved positively in clinic. In this review
we retrospected the scientifific or evidence-based-medicine advances of application and research for modern treatment of PD by CAM
especially traditional Chinese medicine in categories.
Abstract
Parkinson’s disease (PD) is a chronic and progressive degenerative disorder of brain commonly seen among the elderly. As conventionally medical therapy is of limited relief and potential side effects
complementary and alternative medicine (CAM) has attracted growing public and professional attention. Therapies such as acupuncture
musical/rhythmic therapy and deep brain stimulation have been gradually proved positively in clinic. In this review
we retrospected the scientifific or evidence-based-medicine advances of application and research for modern treatment of PD by CAM
especially traditional Chinese medicine in categories.
关键词
Parkinson’s diseasecomplementary and alternative medicineacupunctureChinese Medicinetai chidopaminergic neuronanti-inflflammatoryantioxidant
Keywords
Parkinson’s diseasecomplementary and alternative medicineacupunctureChinese Medicinetai chidopaminergic neuronanti-inflflammatoryantioxidant
references
Wang XP, Chen HZ. Thematic selection: strategies of current drugs and alternative treatments for neurodegenerative diseases. Curr Neuropharmacol 2016;14:301–302.
Staud R. Effectiveness of CAM therapy: understanding the evidence. Rheum Dis Clin North Am 2011;37:9–17.
Lökk J, Nilsson M. Frequency, type and factors associated with the use of complementary and alternative medicine in patients with Parkinson’s disease at a neurological outpatient clinic. Parkinsonism Relat Disord 2010;16:540–544.
Shulman LM, Wen X, Weiner WJ, Bateman D, Minagar A, Duncan R, et al. Acupuncture therapy for the symptoms of Parkinson’s disease. Mov Disord 2002;17:799–802.
Schober A. Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP. Cell Tissue Res 2004;318:215–224.
Fahn S. Parkinson’s disease: 10 years of progress, 1997–2007. Mov Disord 2010;25(Suppl 1):S2–S14.
Yang JL, Chen JSC, Yang YF, Chen JC, Lin CH, Chang RS, et al. Neuroprotection effects of retained acupuncture in neurotoxin-induced Parkinson’s disease mice. Brain Behav Immun 2011;25:1452–1459.
Yeo S, Choi YG, Hong YM, Lim S. Neuroprotective changes of thalamic degeneration-related gene expression by acupuncture in an MPTP mouse model of parkinsonism: microarray analysis. Gene 2013;515:329–338.
Doisson TD, Wieloch T, Diano S, Warden CH, Horvath TL, Mattiasson G. Overexpression of UCP2 protects thalamic neurons following global ischemia in the mouse. J Cereb Blood Flow Meta 2008;28:1186–1195.
Yu YP, Ju WP, Li ZG, Wang DZ, Wang YC, Xie AM. Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat. Brain Res 2010;1336:58–65.
Yin H, Nichols TD, Horowitz JM. Transcription of mouse Sp2 yields alternatively spliced and sub-genomic mRNAs in a tissue-and cell-type-specific fashion. Biochim Biophys Acta 2010;1799:520–531.
Phan D, Cheng CJ, Galfione M, Vakar-Lopez F, Tunstead J, Thompson NE, et al. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigenrelated cell adhesion molecule 1 in tumorigenesis. Cancer Res 2004;64:3072–3078.
Al-Mutairi MS, Cadalbert LC, McGachy HA, Shweash M, Schroeder J, Kurnik M, et al. MAP kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana. PLoS pathogens 2010;6:e1001192.
Choi YG, Yeo S, Hong YM, Lim S. Neuroprotective changes of striatal degeneration-related gene expression by acupuncture in an MPTP mouse model of Parkinsonism: microarray analysis. Cell Mol Neurobio 2011;31:377–391.
Kim ST, Moon W, Chae Y, Kim YJ, Lee H, Park HJ. The effect of electro-acupuncture for 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced proteomic changes in the mouse striatum. J Physiol Sci 2010;60:27–34.
Chae Y, Lee H, Kim H, Kim CH, Chang DI, Kim KM, et al. Parsing brain activity associated with acupuncture treatment in Parkinson’s diseases. Mov Disord 2009;24:1794–1802.
Shen X, Xie YY, Chen C, Wang XP. Effects of electroacupuncture on cognitive function in rats with Parkinson’s disease. Int J Physiol Pathophysiol Pharmacol 2015;7:145–151.
Lam YC, Kum WF, Durairajan SSK, Lu JH, Man SC, Xu M, et al. Efficacy and safety of acupuncture for idiopathic Parkinson’s disease: a systematic review. J Altern Complement Med 2008;14:663–671.
Kim HJ, Jeon BS. Is acupuncture efficacious therapy in Parkinson’s disease? J Neurol Sci 2014;341:1–7.
Lee MS, Shin BC, Kong JC, Ernst E. Effectiveness of acupuncture for Parkinson’s disease: a systematic review. Mov Disord 2008;23:1505–1515.
Chen LW, Wang YQ, Wei LC, Shi M, Chan YS. Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinsons disease. CNS Neurol Disord Drug Targets 2007;6:273–281.
Wang DM, Hai JR, Wei F. Influence of Paning Decoction on non-motor symptoms in Parkinson’s disease. Tradit Chin Drug Res Clin Pharm (Chin) 2012;23:353–356.
Zhao GH, Sun F, Feng XG. Treatment of non-motor symptoms of Parkinson’s disease patients of Gan-Shen deficiency syndrome by Guling Pa’an Granule: a multicenter double-blinded randomized controlled trial. Chin J Integr Tradit West Med (Chin) 2013;33:476–479.
Sun HM, Bai LM, Zhang J. Effects of Yinxing Pingchan Recipe and its components on activity of mitochondrial enzyme complex in brain of mice with Parkinson’s disease. Chin J Integr Tradit West Med (Chin) 2005;25:1008–1011.
Pan T, Fei J, Zhou X, Jankovic J, Le W. Effects of green tea polyphenols on dopamine uptake and on MPP+-induced dopamine neuron injury. Life Sci 2003;72:1073–1083.
Mandel S, Avramovich-Tirosh Y, Reznichenko L, Zheng H, Weinreb O, Amit T, et al. Multifunctional activities of green tea catechins in neuroprotection. Neurosignals 2005;14:46–60.
Choi JY, Park CS, Kim DJ, Cho MH, Jin BK, Pie JE, et al. Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson’s disease in mice by tea phenolic epigallocatechin 3-gallate. Neurotoxicology 2002;23:367–374.
Chen Y, Chen XC. Possible mechanisms of the protective effect of ginsenoside Rg1 on apoptosis in substantia nigra neurons. Acta Pharm Sin (Chin) 2002;37:249–252.
Wu WR, Zhu XZ. Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. Life Sci 1999;65:157–161.
Li X, Matsumoto K, Murakami Y, Tezuka Y, Wu Y, Kadota S. Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice. Pharm Biochem Behav 2005;82:345–352.
Chan YC, Wang MF, Chen YC, Yang DY, Lee MS, Cheng FC. Long-term administration of Polygonum multiflorum Thunb: reduces cerebral ischemia-induced infarct volume in gerbils. Am J Chin Med 2003;31:71–77.
Feng JJ, Li YL, Hou C. The neuron-protective effect of ginkgo biloba extract on rat models of Parkinson’s disease. J Xi’an Jiaotong Univ (Med Sci, Chin) 2011;32:783–786.
Nie G, Jin C, Cao Y, Shen S, Zhao B. Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. Arch Biochem Biophys 2002;397:84–90.
Chen Y, Fang F, Shen S, Zhao B. Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress. Acta Pharmacol Sin 2005;26:56–62.
Gagne JJ, Power MC. Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology 2010;74:995–1002.
Li WJ, Wang JF, Wang XP. Wilson’s disease: update on integrated Chinese and Western medicine. Chin J Integr Med 2013;19:233–240.
Lee H, Kim YO, Kim H, Kim SY, Noh HS, Kang SS, et al. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J 2003;17:1943–1944.
Dajas F, Rivera F, Blasina F, Arredondo F, Echeverry C, Lafon L, et al. Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotoxicity Res 2003;5:425–432.
Lin YL, Lin JK. (–)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol Pharm 1997;52:465–472.
Lee MM, Huang HM, Hsieh MT, Chen CS, Yeh FT, Kuo JS. Anti-inflammatory and neuroprotective effects of magnolol in chemical hypoxia in rat cultured cortical cells in hypoglycemic media. Chin J Physio (Chin) 2000;43:61–68.
Bao YC, Fang X, Zhang B. Effect of Chinese herbal medicine on the immune response of Parkinson’s disease rat model. Clin J Chin Med Pharm (Chin) 2005;17:360–362.
Li G, Ma R, Xu Y. Protective effects of triptolide on the lipopolysaccharide-mediated degeneration of dopaminergic neurons in substantia nigra. Chin J Integr Tradit West Med (Chin) 2006;26:715–718.
He JC, Yuan CX, Wei HC, Chen RX. Effect of Chinese and Western medicine integration on spinning behavior of rats with Parkinson disease. J Chin Integr Med (Chin) 2003;1:293–295.
Kim SD, Allen NE, Canning CG, Fung VS. Postural instability in patients with Parkinson’s disease. CNS Drugs 2013;27:97–112.
Low S, Ang L W, Goh K S, Chew SK. A systematic review of the effectiveness of Tai Chi on fall reduction among the elderly. Arch Gerontol Geriatr 2009;48:325–331.
Hackney ME, Earhart GM. Health-related quality of life and alternative forms of exercise in Parkinson disease. Parkinsonism Relat Disord 2009;15:644–648.
Wang XP, Sun BM, Ding HL. Changes of procedural learning in Chinese patients with non-demented Parkinson disease. Neurosci Lett 2009;449:161–163.
Wang WC, Zhang AL, Rasmussen B, Lin LW, Dunning T, Kang SW, et al. The effect of Tai Chi on psychosocial wellbeing: a systematic review of randomized controlled trials. J Acupunct Meridi Stud 2009;2:171–181.
Zhang LL, Canning SD, Wang XP. Freezing of gait in Parkinsonism and its potential drug treatment. Curr Neuropharmacol 2016;14:302–306.
Li F, Harmer P, Fitzgerald K, Eckstrom E, Stock R, Galver J, et al. Tai Chi and postural stability in patients with Parkinson’s disease. N Engl J Med 2012;366:511–519.
0
浏览量
0
Downloads
3
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 邮编：100091
- 联系电话：010-62886827, 62877592 传真：010-62874291
- 技术支持由北京北大方正电子有限公司提供 京ICP备05067934号-1
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
